'Gastrointestinal bleeding' or 'gastrointestinal hemorrhage' describes every form of
hemorrhage (loss of
blood) in the
gastrointestinal tract, from the
pharynx to the
rectum. It has diverse causes, and a medical history, as well as
physical examination, generally distinguishes between the main forms. The degree of bleeding can range from nearly undetectable to acute, massive, life-threatening bleeding.
Initial emphasis is on resuscitation by infusion of
intravenous fluids and
blood transfusion, treatment with
proton pump inhibitors and occasionally with
vasopressin analogues and
tranexamic acid.
Upper endoscopy or
colonoscopy are generally considered appropriate to identify the source of bleeding and carry out therapeutic interventions.
Symptoms and signs
Gastrointestinal bleeding can range from microscopic bleeding, where the amount of blood is so small that it can only be detected by laboratory testing (in the form of
iron deficiency anemia), to massive bleeding where pure blood is passed and
hypovolemia and
shock may develop, risking
death.
Classification
Gastrointestinal bleeding can be roughly divided into two clinical syndromes.
Upper gastrointestinal bleeding
Main articles: upper gastrointestinal bleeding
Upper gastrointestinal bleeding is from a source between the
pharynx and the
ligament of Treitz. An upper source is characterised by
hematemesis (vomiting up blood) and
melena (tarry stool containing altered blood).
Lower gastrointestinal bleeding
Main articles: Lower gastrointestinal bleeding
Lower gastrointestinal bleeding may be indicated by red blood ''per rectum'', especially in the absence of
hematemesis. Isolated melena may originate from anywhere between the stomach and the proximal colon.
Treatment
Early management
Initial focus in any patient with a form of gastrointestinal hemorrhage is on
resuscitation, as any further intervention is precluded by the presence of intravascular depletion or
shock.
★ ''Fluid resuscitation:''
intravenous fluids and
blood transfusion may be administered.
★ ''Acid suppression'': in an upper GI source,
proton pump inhibitors reduce
gastric acid production and enhance healing of bleeding lesions.
★ ''Inhibition of fibrinolysis'': in ongoing bleeding,
tranexamic acid reduces
fibrinolysis and may decrease blood product requirements.
★ ''Correction of coagulopathy'': if
coagulation parameters (e.g.
prothrombin time) are deranged,
vitamin K or
fresh frozen plasma may need to be administered.
★ ''Reduction of portal pressure'': if the bleeding is thought to be due to
esophageal varices (a complication of
cirrhosis of the liver),
vasopressin analogues and rarely
octreotide may be administered. Rarely, a
Sengstaken-Blakemore tube may be inserted to mechanically compress varices.
★ ''Urgent endoscopy'': if the bleeding cannot be managed medically an urgent
esophagogastroduodenoscopy (EGD/OGD) may identify sources of bleeding. This is a high-risk procedure best performed under safe circumstances in the
intensive care unit or
operating theatres.
★ ''Surgical intervention'': in extreme cases of bleeding,
laparotomy may be required to identify the bleeding source.
Endoscopy
After adequate stabilization,
endoscopy (
upper endoscopy and/or
colonoscopy) are used to identify the source of bleeding. Injection, sclerotherapy, electrocoagulation, vascular clipping and biopsy may be performed.
Endoscopy is also useful in setting the indication for therapy, e.g. the need for long-term
proton pump inhibitor therapy, presence of
esophageal varices,
adenomatous polyps and so on.
Reference
★ Ghosh S, Watts D, Kinnear M. Management of gastrointestinal haemorrhage. ''Postgrad Med J'' 2002;78:4-14. PMID 11796865.